近日，由中国药科大学与上海市皮肤病医院联合主办的"2025皮肤药理与医工转化学术会议"在沪召开。作为会议核心成果，华熙生物联合国内顶尖科研机 构、医疗机构及产业代表，共同发布筹建"中国药理学会皮肤药理专业委员会"的倡议，并围绕细胞外基质（ECM）研究、原料创新与应用转化进行了分享， 为筹建工作提供了坚实的科学基础与产业支撑，进一步推动我国皮肤健康领域跨学科协作进入新阶段。 图：会议现场，右三为华熙生物全球研发平台原料研发中心总经理 王瑞妍 当前，在我国"健康中国"战略持续深化的背景下，皮肤健康产业覆盖皮肤药物、功效护肤品、医疗美容等多个领域，市场规模稳步迈向万亿级。然而，行业 在高速发展中也面临着核心学科建设与产业发展需求脱节、多学科交叉融合不足、高层次复合型人才短缺等挑战。皮肤药理学作为承接基础机制研究、原料 创新、新药开发与临床应用的学科桥梁，其学术组织长期处于空白状态，亟需建立高水平的协同平台。筹建皮肤药理专业委员会，旨在构建"基础研究—技 术开发—临床验证"全链条协作机制，着力突破功效评价与递送技术等关键瓶颈，加速推动行业整体发展。 在科研协作与标准建设方面，华熙生物在ECM领域已形成系统性的学术成果 ...

Core Insights - The skin health industry in China is transitioning from a phase of external variable exploitation to a focus on internal structural refinement, emphasizing the need for continuous solutions from medical treatment to home care [2] - The theme of the SIA2025 conference is "Beauty Across Borders, Professionalism Without Boundaries," highlighting the industry's consensus on cross-disciplinary collaboration [3][5] Group 1: SIA Alliance and Its Initiatives - The SIA Alliance aims to address the challenges of effective collaboration across systems and languages by establishing itself as an "industrial operating system" [5] - The SIA Think Tank has gathered 193 experts from various fields, providing a foundation for quality content and professional insights within the industry [5][6] - The SIA100 scientific evaluation system serves as a bridge between laboratories and the market, establishing unified standards for product evaluation [6] Group 2: Key Reports and Findings - The "2025 China Medical Skincare Clinical Insight Report" was released, translating complex clinical language into actionable guidelines for the industry, focusing on common skin issues [9][11] - The results of the "SIA100 Scientific Products and Technology Achievements Collection" were announced, showcasing significant improvements in the quality and scale of entries compared to 2024 [11][12] Group 3: Research and Innovation - The conference highlighted a shift from "ingredient claims" to "mechanism claims" in efficacy skincare, with research showcasing the neurobiological mechanisms of skin conditions [12][18] - The "Regenerative Medicine Frontier" report illustrated the path from basic research to industrial application, emphasizing advancements in stem cell and exosome research [18] Group 4: Industry Collaboration and Future Directions - The "Medical Research Co-Creation Forum" aims to bridge clinical needs with industry innovations, showcasing the importance of collaborative efforts in addressing unmet clinical demands [19] - The SIA2025 conference reflects a clear industry shift towards cross-disciplinary integration, with success depending on the depth and systematic nature of professional collaboration [20]